Expression of genes for redox-dependent glutathione S-transferase isoforms GSTP1-1 and GSTA4-4 in tumor cell during the development doxorubicin resistance

Bulletin of Experimental Biology and Medicine

Volumn 143, Issue 3, 2007, Pages 328-330

  Kalinina, E V ^a,b   Chernov, N N ^a   Saprin, A N ^a   Kotova, Ya N ^a   Remizov, V I ^a   Shcherbak, N P ^a  

^a CENTER FOR THEORETICAL PROBLEMS OF PHYSICOCHEMICAL PHARMACOLOGY   (Russian Federation)

^b PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

Author keywords

Doxorubicin; Drug resistance; Glutathione S transferase isoforms GSTP1 1 and GSTA4 4

Indexed keywords

DOXORUBICIN; GLUTATHIONE TRANSFERASE A4; GLUTATHIONE TRANSFERASE P1;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN K 562; CELL STRAIN MCF 7; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; OVARY CARCINOMA; OXIDATION REDUCTION STATE; PHARMACOGENETICS;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; K562 CELLS; NEOPLASMS; OVARIAN NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM;

EID: 34548209137     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0102-2     Document Type: Article

References (12)

1. E. V. Kalinina, A. N. Saprin, V. S. Solomka, et al., Vopr. Onkol., 49, No. 3, 294-298 (2003).
2. P. Alin, H. Danielson, and B. Mannervik, FEBS Lett., 179, No. 2, 267-270 (1985).
3. R. N. Armstrong, Clin. Res. Toxicol., 1, 2-18 (1997).
4. K. Berhame, M. Widersten, A. Engstrom, et al., Proc. Natl. Acad. Sci. USA, 91, 1480-1484 (1994).
5. F. Desmots, M. Rissel, C. Pigeon, et al., Free Radic. Biol. Med., 32, No. 1, 93-101 (2002).
6. D. Dreher and A. F. Junord, Eur. J. Cancer, 32, 30-38 (1996).
7. H. Esterbrauer, R. J. Schaur, and H. Zollner, Free Radic. Biol. Med., 11, 81-87 (1991).
8. D. A. Gewirtz, Biochem. Pharmacol., 57, 727-741 (1999).
9. W. H. Habig, M. J. Pabst, and W. B. Jakoby, J. Biol. Chem., 249, 7130-7139 (1974).
10. J. D. Hayes, J. U. Flanagan, and I. R. Jowsey, Annu. Rev. Pharmacol. Toxicol., 45, 51-88 (2005).
11. K. Nakagawa, N. Saijo, S. Tsuchida, et al., J. Biol. Chem., 265, 4296-4301 (1990).
12. D. M. Townsend and K. D. Tew, Am. J. Pharmacogenomics, 3, 157-172 (2003).